AU563556B2 - Substituted 6-aryl-1,2,4-triazolo (4,3-b) pyridazines - Google Patents

Substituted 6-aryl-1,2,4-triazolo (4,3-b) pyridazines

Info

Publication number
AU563556B2
AU563556B2 AU26346/84A AU2634684A AU563556B2 AU 563556 B2 AU563556 B2 AU 563556B2 AU 26346/84 A AU26346/84 A AU 26346/84A AU 2634684 A AU2634684 A AU 2634684A AU 563556 B2 AU563556 B2 AU 563556B2
Authority
AU
Australia
Prior art keywords
carbon atoms
formula
chlorine
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU26346/84A
Other versions
AU2634684A (en
Inventor
Franz Hock
Manfred Rosner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU2634684A publication Critical patent/AU2634684A/en
Application granted granted Critical
Publication of AU563556B2 publication Critical patent/AU563556B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 1. Compounds of the formula see diagramm : EP0121490,P11,F1 and salts thereof with a physiologically acceptable acid, in which formula R**1 and R**2 are identical or different and represent hydrogen, alkyl groups having 1-6 carbon atoms, phenyl or chlorine, R**3 denotes linear or branched alkyl having 1-6 carbon atoms, cycloalkyl having 3-8 carbon atoms, phenylalkyl which has 1-4 carbon atoms in the alkyl part and is optionally monosubstituted, disubstituted or trisubstituted in the phenyl part by fluorine, chlorine, bromine, iodine, trifluoromethyl or alkyl having 1-4 carbon atoms, alkylcarbonyl having 1-6 carbon atoms in the alkyl part, cycloalkylcarbonyl having 5-7 carbon atoms in the cycloalkyl part, or benzoyl which is optionally monosubstituted, disubstituted or trisubstituted by fluorine, chlorine, bromine, iodine, trifluoromethyl or alkyl having 1-4 carbon atoms, or denotes Ar, and in which Ar represents phenyl, phenoxyphenyl, phenylthiophenyl, 2-thienyl or 2-furyl, these radicals being optionally monosubstituted or disubstituted by fluorine, chlorine, alkyl groups having 1-6 carbon atoms, cyano or trifluoromethyl, with the exception of compounds of the formula I in which R**1 and R**2 denote hydrogen, R**3 denotes phenyl and Ar denotes phenyl or 4-methylphenyl. For the Contracting State AT 1. A process for the preparation of compounds of the formula I see diagramm : EP0121490,P13,F1 and salts thereof with a physiologically acceptable acid, in which formula R**1 and R**2 are identical or different and represent hydrogen, alkyl groups having 1-6 carbon atoms, phenyl or chlorine, R**3 denotes linear or branched alkyl having 1-6 carbon atoms, cycloalkyl having 3-8 carbon atoms, phenylalkyl which has 1-4 carbon atoms in the alkyl part and is optionally monosubstituted, disubstituted or trisubstituted in the phenyl part by fluorine, chlorine, bromine, iodine, trifluoromethyl or alkyl having 1-4 carbon atoms, alkylcarbonyl having 1-6 carbon atoms in the alkyl part, cycloalkylcarbonyl having 5-7 carbon atoms in the cycloalkyl part, or benzoyl which is optionally monosubstituted, disubstituted or trisubstituted by fluorine, chlorine, bromine, iodine, trifluoromethyl or alkyl having 1-4 carbon atoms, or denotes Ar, and in which Ar represents phenyl, phenoxyphenyl, phenylthiophenyl, 2-thienyl or 2-furyl, these radicals being optionally monosubstituted or disubstituted by fluorine, chlorine, alkyl groups having 1-6 carbon atoms, cyano or trifluoromethyl, with the exception of compounds of the formula I in which R**1 and R**2 denote hydrogen, R**3 denotes phenyl and Ar denotes phenyl or 4-methylphenyl, which comprises a) cyclizing a compound of the formula II see diagramm : EP0121490,P13,F2 in which Ar, R**1, R**2 and R**3 have the meanings indicated for formula I and Z represents O or S, by heating, if appropriate with the addition of a condensation agent, to give a compound of the formula I, or b) by reacting a compound of the formula III see diagramm : EP0121490,P13,F3 in which R**6 denotes chlorine, bromine or methylthio and Ar, R**1 and R**2 have the meanings indicated for formula I, with an amine of the formule IV see diagramm : EP0121490,P14,F4 in which R**3 has the meaning indicated for formula I, or c) reacting, if appropriate with the addition of a condensation agent or catalyst, a compound of the formula V see diagramm : EP0121490,P14,F5 or one of its salts in which Ar, R**1 and R**2 have the meanings indicated for formula I, with a compound of the formula VI R**3-Y in which R**3 has the meaning indicated for formula I and Y represents a leaving group, such as, for example, fluorine, chlorine, bromine, iodine, see diagramm : EP0121490,P14,F6 or the tosylate radical, and, if appropriate, converting a compound thus obtained into a salt thereof by adding a physiologically acceptable acid.
AU26346/84A 1983-03-31 1984-03-30 Substituted 6-aryl-1,2,4-triazolo (4,3-b) pyridazines Ceased AU563556B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833311753 DE3311753A1 (en) 1983-03-31 1983-03-31 SUBSTITUTED 6-ARYL-1,2,4-TRIAZOLO (4,3-B) PYRIDAZINE - THEIR PRODUCTION AND USE -
DE3311753 1983-03-31

Publications (2)

Publication Number Publication Date
AU2634684A AU2634684A (en) 1984-10-04
AU563556B2 true AU563556B2 (en) 1987-07-16

Family

ID=6195196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26346/84A Ceased AU563556B2 (en) 1983-03-31 1984-03-30 Substituted 6-aryl-1,2,4-triazolo (4,3-b) pyridazines

Country Status (19)

Country Link
EP (1) EP0121490B1 (en)
JP (1) JPS59184179A (en)
KR (1) KR840008361A (en)
AT (1) ATE32723T1 (en)
AU (1) AU563556B2 (en)
CA (1) CA1246568A (en)
DE (2) DE3311753A1 (en)
DK (1) DK144884A (en)
ES (1) ES8501765A1 (en)
FI (1) FI841238A (en)
GR (1) GR81812B (en)
HU (1) HU189076B (en)
IL (1) IL71412A (en)
MA (1) MA20080A1 (en)
NO (1) NO841270L (en)
NZ (1) NZ207691A (en)
PH (1) PH20465A (en)
PT (1) PT78343B (en)
ZA (1) ZA842389B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
US7683060B2 (en) 2006-08-07 2010-03-23 Incyte Corporation Triazolotriazines as kinase inhibitors
PL2099447T3 (en) 2006-11-22 2013-06-28 Incyte Holdings Corp Imidazotriazines and imidazopyrimidines as kinase inhibitors
HUE034716T2 (en) 2008-05-21 2018-02-28 Incyte Holdings Corp Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
CN102812027B (en) 2010-02-03 2015-01-07 因西特公司 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
WO2012148775A1 (en) * 2011-04-29 2012-11-01 Amgen Inc. Bicyclic pyridazine compounds as pim inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128809C (en) * 1966-06-18
DE2113438A1 (en) * 1971-03-19 1972-09-21 Boehringer Mannheim Gmbh Anti-microbial nitrofuryl-triazolo -(4,3-b) - pyridazine derivs - used for treating urinary system infections
US3915968A (en) * 1973-09-21 1975-10-28 Lepetit Spa Triazolopyridazines
DE3217325A1 (en) * 1982-05-08 1983-11-10 Hoechst Ag, 6230 Frankfurt 3-AMINO-6-ARYL-1,2,4-TRIAZOLO (4,3-B) -PYRIDAZINE, THEIR PRODUCTION AND USE
DE3222342A1 (en) * 1982-06-14 1983-12-15 Hoechst Ag, 6230 Frankfurt 6-Aryl-1,2,4-triazolo[4,3-b]pyridazine-3-carbamates, their preparation and medicaments containing them

Also Published As

Publication number Publication date
ZA842389B (en) 1984-11-28
NZ207691A (en) 1986-07-11
EP0121490A1 (en) 1984-10-10
HU189076B (en) 1986-06-30
GR81812B (en) 1984-12-12
ES531084A0 (en) 1984-12-01
PT78343A (en) 1984-04-01
FI841238A (en) 1984-10-01
IL71412A (en) 1988-05-31
DK144884A (en) 1984-10-01
NO841270L (en) 1984-10-01
EP0121490B1 (en) 1988-03-02
HUT34193A (en) 1985-02-28
AU2634684A (en) 1984-10-04
MA20080A1 (en) 1984-10-01
KR840008361A (en) 1984-12-14
ATE32723T1 (en) 1988-03-15
DE3311753A1 (en) 1984-10-04
ES8501765A1 (en) 1984-12-01
DK144884D0 (en) 1984-02-29
FI841238A0 (en) 1984-03-28
IL71412A0 (en) 1984-06-29
PT78343B (en) 1986-07-14
CA1246568A (en) 1988-12-13
PH20465A (en) 1987-01-14
DE3469530D1 (en) 1988-04-07
JPS59184179A (en) 1984-10-19

Similar Documents

Publication Publication Date Title
KR940005338B1 (en) Process for phosphorylation
AU563556B2 (en) Substituted 6-aryl-1,2,4-triazolo (4,3-b) pyridazines
ES509533A0 (en) "PROCEDURE FOR THE PREPARATION OF NEW BENZOXAZOLES AND BENZOTIAZOLES".
ES535627A0 (en) PROCEDURE FOR PREPARING DEOXYRIBONUCLEOSIDE PHOSPHONATES
ATE12039T1 (en) SUBSTITUTED AZOLYL GLYCOLSULFONATES, FUNGICIDES CONTAINING THEM AND PROCESS FOR THEIR PRODUCTION.